Home R&D

R&D

Takeda & Arrowhead to co-develop RNAi therapy for AATLD
Featured

Takeda & Arrowhead to co-develop RNAi therapy for AATLD

Dominic Cuthbert -
0
AstraZeneca’s long-acting antibody combo advances into Phase III clinical trials
Featured

AstraZeneca’s long-acting antibody combo advances into Phase III clinical trials

Dominic Cuthbert -
0
EMA starts first rolling review of COVID-19 vaccine
Featured

EMA starts first rolling review of COVID-19 vaccine

Dominic Cuthbert -
0
Pfizer & CStone address oncological needs in China
Featured

Pfizer & CStone address oncological needs in China

Dominic Cuthbert -
0
Iksuda Therapeutics enters license agreement to develop new generation of antibody drug conjugates
Featured

Iksuda Therapeutics enters license agreement to develop new generation of antibody drug conjugates

Tess Egginton -
0
Study begins evaluating implementation of ViiV’s HIV regimen in European clinical practices
Featured

Study begins evaluating implementation of ViiV’s HIV regimen in European clinical practices

Dominic Cuthbert -
0
Nasal spray reduces viral replication by up to 96% in COVID-19 study
Featured

Nasal spray reduces viral replication by up to 96% in COVID-19 study

Dominic Cuthbert -
0
Genentech enters genetic modifier collaboration with Scenic Biotech
Featured

Genentech enters genetic modifier collaboration with Scenic Biotech

Dominic Cuthbert -
0
Scientists share promising COVID-19 drug development breakthrough
Featured

Scientists share promising COVID-19 drug development breakthrough

Dominic Cuthbert -
0
Valneva forges COVID-19 vaccine partnership with UK Gov
Featured

Valneva forges COVID-19 vaccine partnership with UK Gov

Dominic Cuthbert -
0
123...176Page 1 of 176

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks